- Overview
- Our Advantages
- FAQ
Basic Info.
Model NO.
JF002
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Adult
State
Powder
Purity
>99%
Intermediate
Apixaban-2
Other Name
(Arry-470)
Sample
Free
Supplier
Apixaban Factory
Heavy Metal
10ppm
Impurity
0.01%
Ros
Yes
Annul Sales
2000kg
Capacity
25000kg
Stock
2.00kg
Water
0.01%
Market
Globle
Ever Exported?
Yes
Volume
200kg
Experience
10years
Transport Package
Air
Specification
JP
Trademark
jianfeng
Origin
Shandong
HS Code
2939000000
Product Description
High Quality API Powder Apixaban Intermediate CAS 27143-07-3 with Best Price
Our company sells more than 5 tons of Apixaban Intermediate to domestic export trading companies every year.In recent years, we have started to do foreign market. Please contact me to obtain the factory price.
| 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | 503614-91-3 | Apixaban intermediate | ||||
| Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester | 27143-07-3 | Apixaban intermediate | ||||
| 2(1H)-pyridine,3-chloro-5,6-dihydro-1-(4-nitrophenyl) | 536760-29-9 | Apixaban intermediate | ||||
| 3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-pyridin-2-one | 545445-44-1 | Apixaban intermediate | ||||
| 3-(4-Morpholinyl)-1-(4-nitrophenyl)-5,6-dihydro-2(1H)-pyridinone | 503615-03-0 | Apixaban intermediate | ||||
| Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3 | 536759-91-8 | Apixaban intermediate | ||||
| ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503615-07-4 | Apixaban intermediate | ||||
| 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone | 1267610-26-3 | Apixaban intermediate | ||||
Apixaban is an anticoagulant used to reduce the risk of stroke and systemic embolism in patients with non valvular atrial fibrillation.
A key component in helping our customers be first to market is a responsive supply chain. We achieve this by making sure that all our facilities are operating efficiently and to the latest standards of quality, safety, and productivity. A strong interconnect between business and factories allows for a quick reaction to dynamic market changes, so that we can avert shortages and meet sudden surges in demand.
Apixaban is a selective inhibitor of FXa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound FXa, and prothrombinase activity. Apixaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, apixaban decreases thrombin generation and thrombus development
